RADIODERMATITIS MARKET ANALYSIS

Radiodermatitis Market, By Product Type (Topical Agents( Corticosteroids, Hydrophilic Creams, Others), Oral Medication( Corticosteroids, Other, Analgesic & Anti-Inflammatory) Dressings ( Hydrogel, Hydrocolloid, No Sting Barrier Film, Honey Impregnated Dressing, Silicone coated Dressing, Others ), By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : Jul 2023
Code : CMI3881
Pages :160
Formats :
Excel and PDF
Industry : Pharmaceutical

Market News

Global Radiodermatitis Market: Key Developments

On May 4, 2023, Albert Einstein College of Medicine, U.S explained a simple antibacterial treatment solves a severe skin problem caused by radiation therapy, Staphylococcus aureus (SA), often shortened to "staph", usually lives harmlessly on the skin, often in the nose and armpits. But they can cause infections if the skin of the incision breaks. Radiation weakens the skin structure at the treatment site and can cause infection, allowing SA to penetrate the outer layer of the skin.

On September 15, 2022, BMG Pharma, Italy based pharmaceutical company and HTL Biotechnology, France based biotechnology company signed an agreement for the production of the functional ingredient underlying the patented Hyaluromimethic technology works on Sodium Hyaluronate Lipoate Formate (SHLF) to develop solutions in aesthetic dermatology, ophthalmology, and arthrosis. SHLF’s properties including improved resistance to enzymatic degradation, self-crosslinking properties, and elastic modulus are of great interest in dermo-aesthetic and osteoarthritis medicine.